Sort
17,288 grants matching “multiple sclerosis”
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
$676,854Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2013 · MH
Clinical Resources Key Componient Activity
$676,721R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2013 · GM
Automated MR Image Analysis in MS: Identification of a Surrogate
$676,658Ponnada A Narayana · University Of Texas Hlth Sci Ctr Houston · R01 · FY2009 · EB
Design and development of HDAC11-specific chemical inhibitors for disease treatments
$676,591Edward Seto · George Washington University · R01 · FY2025 · AI
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE
$676,340Brigham And Women'S Hospital · U19 · FY2001 · AI
Wireless Movement Disorder Monitor
$675,278Joseph P Giuffrida · Cleveland Medical Devices, Inc. · R44 · FY2008 · NS
Engineered probiotic for the treatment of autoimmune diseases
$675,152Christine Beeton · Baylor College Of Medicine · R01 · FY2024 · AI
Diagnostic and Natural History Markers in ALS
$675,094Columbia University Health Sciences · R01 · FY2003 · NS
Role of Poldip2 in endothelial barrier function and inflammation in the lung
$674,817Kathy K Griendling · Emory University · R56 · FY2020 · HL
Marijuana Use in Older Adults: Health, Function and Fall-Related Injury
$674,449Salomeh Keyhani · Northern California Institute/Res/Edu · R01 · FY2019 · AG
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD
$674,414Justin Kawika Ichida · University Of Southern California · R01 · FY2020 · NS
Fetal-Derived Exosome Cargos in Maternal Blood to Predict Fetal Alcohol Syndrome
$674,295Michael Edgar Selzer · Temple Univ Of The Commonwealth · R01 · FY2025 · AA
Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis
$673,559Ellen M. Mowry · Johns Hopkins University · R01 · FY2023 · NR
Control Of G Protein Signaling: Role Of The RGSs
$673,485John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
ANTIGEN PRESENTATION IN HUMAN AUTOIMMUNE DISEASES
$673,375Dana-Farber Cancer Institute · P01 · FY2001 · AI
Assessment of Ultrsound-facilitated Neurotherapeutics in Alzheimer's Disease
$673,114Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2020 · AG
Training Program in Immunology and Immunogenetics
$672,919Paul M Allen · Washington University · T32 · FY2011 · AI
Virus-driven human gene misregulation in disease
$672,881Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HG
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
$672,866Susan Ruth Schwab · New York University School Of Medicine · R01 · FY2020 · AI
Virus-driven human gene misregulation in disease
$672,600Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HG
High-Resolution, Anisotropic MR Elastography of the Brain
$672,245Curtis L Johnson · University Of Delaware · R01 · FY2021 · EB
CAR-T cell treatment of CNS Autoimmunity
$671,939Gregory Wu · Washington University · R01 · FY2022 · AI
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
$671,651Jung-Hyun Park · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$671,571Tracy M Handel · University Of California, San Diego · R01 · FY2023 · AI
Genome-wide Light-inducible Tuning of Transcriptional Network Dynamic
$671,425Paola Arlotta · Massachusetts General Hospital · R01 · FY2010 · NS